RNA isothermal amplification technology is a molecular biology technology used to amplify specific RNA fragments. Its main technical principle is to first generate a double-stranded DNA copy of the target nucleic acid (RNA) by reverse transcriptase at the same temperature. , and then use RNA polymerase to generate multiple RNA copies from the DNA copy; sometimes, each newly generated RNA copy can also enter the next cycle from reverse transcription; to achieve the purpose of exponentially amplifying RNA.
Highlights
The global RNA Isothermal Amplification Technology market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North American market for RNA Isothermal Amplification Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific market for RNA Isothermal Amplification Technology is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global market for RNA Isothermal Amplification Technology in Infection Detection Field is estimated to increase from $ million in 2023 to $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The key global companies of RNA Isothermal Amplification Technology include HOLOGIC, Becton, BioHelix Corporation, BioMerieux Biotechnology Company, Thermo Fisher, Wuhan Zhongzhi Biotechnology, Shanghai Rendu Biotechnology, Shengxiang Biotechnology and Shanghai Liferiver, etc. In 2022, the world's top three vendors accounted for approximately % of the revenue.
Report Scope
This report aims to provide a comprehensive presentation of the global market for RNA Isothermal Amplification Technology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Isothermal Amplification Technology.
The RNA Isothermal Amplification Technology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global RNA Isothermal Amplification Technology market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the RNA Isothermal Amplification Technology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by type, by application, and by regions.
By Company
HOLOGIC
Becton
BioHelix Corporation
BioMerieux Biotechnology Company
Thermo Fisher
Wuhan Zhongzhi Biotechnology
Shanghai Rendu Biotechnology
Shengxiang Biotechnology
Shanghai Liferiver
Jiangsu Shuoshi Biotechnology Co., Ltd.
AmoyDx
Segment by Type
Endpoint Method
Real-time Fluorescence detection
Segment by Application
Infection Detection Field
Tumor Detection Field
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of RNA Isothermal Amplification Technology companies鈥� competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the key companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 麻豆原创 Analysis by Type
1.2.1 Global RNA Isothermal Amplification Technology 麻豆原创 Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Endpoint Method
1.2.3 Real-time Fluorescence detection
1.3 麻豆原创 by Application
1.3.1 Global RNA Isothermal Amplification Technology 麻豆原创 Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Infection Detection Field
1.3.3 Tumor Detection Field
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global RNA Isothermal Amplification Technology 麻豆原创 Perspective (2018-2029)
2.2 RNA Isothermal Amplification Technology Growth Trends by Region
2.2.1 Global RNA Isothermal Amplification Technology 麻豆原创 Size by Region: 2018 VS 2022 VS 2029
2.2.2 RNA Isothermal Amplification Technology Historic 麻豆原创 Size by Region (2018-2023)
2.2.3 RNA Isothermal Amplification Technology Forecasted 麻豆原创 Size by Region (2024-2029)
2.3 RNA Isothermal Amplification Technology 麻豆原创 Dynamics
2.3.1 RNA Isothermal Amplification Technology Industry Trends
2.3.2 RNA Isothermal Amplification Technology 麻豆原创 Drivers
2.3.3 RNA Isothermal Amplification Technology 麻豆原创 Challenges
2.3.4 RNA Isothermal Amplification Technology 麻豆原创 Restraints
3 Competition Landscape by Key Players
3.1 Global Top RNA Isothermal Amplification Technology Players by Revenue
3.1.1 Global Top RNA Isothermal Amplification Technology Players by Revenue (2018-2023)
3.1.2 Global RNA Isothermal Amplification Technology Revenue 麻豆原创 Share by Players (2018-2023)
3.2 Global RNA Isothermal Amplification Technology 麻豆原创 Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by RNA Isothermal Amplification Technology Revenue
3.4 Global RNA Isothermal Amplification Technology 麻豆原创 Concentration Ratio
3.4.1 Global RNA Isothermal Amplification Technology 麻豆原创 Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by RNA Isothermal Amplification Technology Revenue in 2022
3.5 RNA Isothermal Amplification Technology Key Players Head office and Area Served
3.6 Key Players RNA Isothermal Amplification Technology Product Solution and Service
3.7 Date of Enter into RNA Isothermal Amplification Technology 麻豆原创
3.8 Mergers & Acquisitions, Expansion Plans
4 RNA Isothermal Amplification Technology Breakdown Data by Type
4.1 Global RNA Isothermal Amplification Technology Historic 麻豆原创 Size by Type (2018-2023)
4.2 Global RNA Isothermal Amplification Technology Forecasted 麻豆原创 Size by Type (2024-2029)
5 RNA Isothermal Amplification Technology Breakdown Data by Application
5.1 Global RNA Isothermal Amplification Technology Historic 麻豆原创 Size by Application (2018-2023)
5.2 Global RNA Isothermal Amplification Technology Forecasted 麻豆原创 Size by Application (2024-2029)
6 North America
6.1 North America RNA Isothermal Amplification Technology 麻豆原创 Size (2018-2029)
6.2 North America RNA Isothermal Amplification Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America RNA Isothermal Amplification Technology 麻豆原创 Size by Country (2018-2023)
6.4 North America RNA Isothermal Amplification Technology 麻豆原创 Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe RNA Isothermal Amplification Technology 麻豆原创 Size (2018-2029)
7.2 Europe RNA Isothermal Amplification Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe RNA Isothermal Amplification Technology 麻豆原创 Size by Country (2018-2023)
7.4 Europe RNA Isothermal Amplification Technology 麻豆原创 Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific RNA Isothermal Amplification Technology 麻豆原创 Size (2018-2029)
8.2 Asia-Pacific RNA Isothermal Amplification Technology 麻豆原创 Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific RNA Isothermal Amplification Technology 麻豆原创 Size by Region (2018-2023)
8.4 Asia-Pacific RNA Isothermal Amplification Technology 麻豆原创 Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America RNA Isothermal Amplification Technology 麻豆原创 Size (2018-2029)
9.2 Latin America RNA Isothermal Amplification Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America RNA Isothermal Amplification Technology 麻豆原创 Size by Country (2018-2023)
9.4 Latin America RNA Isothermal Amplification Technology 麻豆原创 Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa RNA Isothermal Amplification Technology 麻豆原创 Size (2018-2029)
10.2 Middle East & Africa RNA Isothermal Amplification Technology 麻豆原创 Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa RNA Isothermal Amplification Technology 麻豆原创 Size by Country (2018-2023)
10.4 Middle East & Africa RNA Isothermal Amplification Technology 麻豆原创 Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 HOLOGIC
11.1.1 HOLOGIC Company Detail
11.1.2 HOLOGIC Business Overview
11.1.3 HOLOGIC RNA Isothermal Amplification Technology Introduction
11.1.4 HOLOGIC Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.1.5 HOLOGIC Recent Development
11.2 Becton
11.2.1 Becton Company Detail
11.2.2 Becton Business Overview
11.2.3 Becton RNA Isothermal Amplification Technology Introduction
11.2.4 Becton Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.2.5 Becton Recent Development
11.3 BioHelix Corporation
11.3.1 BioHelix Corporation Company Detail
11.3.2 BioHelix Corporation Business Overview
11.3.3 BioHelix Corporation RNA Isothermal Amplification Technology Introduction
11.3.4 BioHelix Corporation Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.3.5 BioHelix Corporation Recent Development
11.4 BioMerieux Biotechnology Company
11.4.1 BioMerieux Biotechnology Company Company Detail
11.4.2 BioMerieux Biotechnology Company Business Overview
11.4.3 BioMerieux Biotechnology Company RNA Isothermal Amplification Technology Introduction
11.4.4 BioMerieux Biotechnology Company Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.4.5 BioMerieux Biotechnology Company Recent Development
11.5 Thermo Fisher
11.5.1 Thermo Fisher Company Detail
11.5.2 Thermo Fisher Business Overview
11.5.3 Thermo Fisher RNA Isothermal Amplification Technology Introduction
11.5.4 Thermo Fisher Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.5.5 Thermo Fisher Recent Development
11.6 Wuhan Zhongzhi Biotechnology
11.6.1 Wuhan Zhongzhi Biotechnology Company Detail
11.6.2 Wuhan Zhongzhi Biotechnology Business Overview
11.6.3 Wuhan Zhongzhi Biotechnology RNA Isothermal Amplification Technology Introduction
11.6.4 Wuhan Zhongzhi Biotechnology Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.6.5 Wuhan Zhongzhi Biotechnology Recent Development
11.7 Shanghai Rendu Biotechnology
11.7.1 Shanghai Rendu Biotechnology Company Detail
11.7.2 Shanghai Rendu Biotechnology Business Overview
11.7.3 Shanghai Rendu Biotechnology RNA Isothermal Amplification Technology Introduction
11.7.4 Shanghai Rendu Biotechnology Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.7.5 Shanghai Rendu Biotechnology Recent Development
11.8 Shengxiang Biotechnology
11.8.1 Shengxiang Biotechnology Company Detail
11.8.2 Shengxiang Biotechnology Business Overview
11.8.3 Shengxiang Biotechnology RNA Isothermal Amplification Technology Introduction
11.8.4 Shengxiang Biotechnology Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.8.5 Shengxiang Biotechnology Recent Development
11.9 Shanghai Liferiver
11.9.1 Shanghai Liferiver Company Detail
11.9.2 Shanghai Liferiver Business Overview
11.9.3 Shanghai Liferiver RNA Isothermal Amplification Technology Introduction
11.9.4 Shanghai Liferiver Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.9.5 Shanghai Liferiver Recent Development
11.10 Jiangsu Shuoshi Biotechnology Co., Ltd.
11.10.1 Jiangsu Shuoshi Biotechnology Co., Ltd. Company Detail
11.10.2 Jiangsu Shuoshi Biotechnology Co., Ltd. Business Overview
11.10.3 Jiangsu Shuoshi Biotechnology Co., Ltd. RNA Isothermal Amplification Technology Introduction
11.10.4 Jiangsu Shuoshi Biotechnology Co., Ltd. Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.10.5 Jiangsu Shuoshi Biotechnology Co., Ltd. Recent Development
11.11 AmoyDx
11.11.1 AmoyDx Company Detail
11.11.2 AmoyDx Business Overview
11.11.3 AmoyDx RNA Isothermal Amplification Technology Introduction
11.11.4 AmoyDx Revenue in RNA Isothermal Amplification Technology Business (2018-2023)
11.11.5 AmoyDx Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
HOLOGIC
Becton
BioHelix Corporation
BioMerieux Biotechnology Company
Thermo Fisher
Wuhan Zhongzhi Biotechnology
Shanghai Rendu Biotechnology
Shengxiang Biotechnology
Shanghai Liferiver
Jiangsu Shuoshi Biotechnology Co., Ltd.
AmoyDx
听
听
*If Applicable.
